Search Results - "Gresham, Louise M"

Response to comment on “An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.” by Gresham, Louise M., Marzario, Barbara, Dutz, Jan, Kirchhof, Mark G.

Get full text

Wearable activity monitors in oncology trials: Current use of an emerging technology by Gresham, Gillian, Schrack, Jennifer, Gresham, Louise M., Shinde, Arvind M., Hendifar, Andrew E., Tuli, Richard, Rimel, B.J., Figlin, Robert, Meinert, Curtis L., Piantadosi, Steven

“…Physical activity is an important outcome in oncology trials. Physical activity is commonly assessed using self-reported questionnaires, which are limited by…”
Get full text

A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report by Gresham, Louise M, Kirchhof, Mark G

“…Bullous pemphigoid is an acquired autoimmune subepidermal blistering disease that can arise following exposure to systemic medication, referred to as…”
Get full text

An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology by Gresham, Louise M., Marzario, Barbara, Dutz, Jan, Kirchhof, Mark G.

“…Immune-mediated diseases and immunotherapeutics can negatively affect normal immune functioning and, consequently, vaccine safety and response. The COVID-19…”
Get full text

Evaluation of the effectiveness of an enhanced recovery after surgery program using data from the National Surgical Quality Improvement Program by Gresham, Louise M, Sadiq, Manahil, Gresham, Gillian, McGrath, Maureen, Lacelle, Kiley, Szeto, Michael, Trickett, John, Schramm, David, Pearsall, Emily, McKenzie, Marg, McLeod, Robin, Auer, Rebecca C

“…Background: Barriers exist in implementing enhanced recovery after surgery (ERAS), which aims to decrease postoperative complication rates and length of stay,…”
Get full text

Longitudinal Stability of Cognition in Early-Phase Relapsing-Remitting Multiple Sclerosis: Does Cognitive Reserve Play a Role? by Barbu, Roxana M, Berard, Jason A, Gresham, Louise M, Walker, Lisa A S

“…Up to 70% of people with multiple sclerosis (MS) experience cognitive impairment. Some remain cognitively intact despite advanced disease. Cognitive reserve…”
Get full text

Longitudinal Stability of Cognition in Early-Phase Relapsing-Remitting Multiple Sclerosis by Barbu, Roxana M., Berard, Jason A., Gresham, Louise M., Walker, Lisa A.S.

“…Abstract Background: Up to 70% of people with multiple sclerosis (MS) experience cognitive impairment. Some remain cognitively intact despite advanced disease…”
Get full text

Reactive infectious mucocutaneous eruption following COVID-19 infection in vaccinated patients by Aw, Michael, Gresham, Louise, Spurr, Alison, Gavigan, Genevieve

Get full text

A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report by Gresham, Louise M, Kirchhof, Mark G

Get full text